Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
Clinical trial NCT05599984 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05599984
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2027-11-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.